Forgotten Password   ::   No Account? REGISTER!


SEAS Trial Checks Merck-Schering-Plough

By mirol 124 days ago from http://mikelorimer.bloggerunleashed.com

New testing of drug combination Vytorin may reveal results that are unfavorable to Merck and Schering Plough. They are holding back their earnings statements until the study results are in. Why would it matter? If the test results are bad Vytorin sales tank. If the study is favorable sales climb. But the delay in earnings statements smacks of coverup and opportunity for executives' stock selling.

avatar

Tags: seas trial vytorin merck schering plough zetia cholesterol atheroschlerosis alzheimers hdl ldl arteriochlerosis prehypertensive


Comments
 
Who Zoomed
 
Related Links